You have 9 free searches left this month | for more free features.

Myelin Gene

Showing 1 - 25 of 5,969

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

Not yet recruiting
  • Monoclonal Gammopathy of Uncertain Significance
  • Zanubrutinib Oral Product
  • Utrecht, Netherlands
    University Medical Center Utrecht
Jul 6, 2023

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Trial in Germany, Italy, United States (Satralizumab,

Recruiting
  • Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
  • Washington, District of Columbia
  • +3 more
Aug 2, 2022

Central and Peripheral Nervous System Changes as Markers of

Completed
  • Multiple Sclerosis
  • +7 more
    • Sønderborg, Jylland, Denmark
      Department of Neurology (Skleroseklinikken), Sygehus Sønderjylla
    Oct 13, 2021

    Metachromatic Leukodystrophy, Adrenoleukodystrophy Trial in Shenzhen (transduced CD34+ hematopoietic stem cell)

    Recruiting
    • Metachromatic Leukodystrophy
    • Adrenoleukodystrophy
    • transduced CD34+ hematopoietic stem cell
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital, The First Affiliated Hospital
    May 25, 2022

    Myelin Imaging in Concussed High School Football Players

    Terminated
    • Traumatic Brain Injury
    • McDESPOT
    • Hollywood, Florida
      Memorial Healthcare System
    Sep 23, 2020

    Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD) Trial in Worldwide (Rozanolixizumab, Placebo)

    Recruiting
    • Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)
    • Scottsdale, Arizona
    • +43 more
    Feb 2, 2023

    CMT1A Trial in France (EllaOne, EllaOne )

    Terminated
    • CMT1A
    • Besançon, France
    • +4 more
    Jul 20, 2022

    Sensitivity and Specificity of TSA-CBA for Autoantibodies

    Recruiting
    • NMO Spectrum Disorder
    • +6 more
    • CBA-TSA
    • Beijing, Beijing, China
      Beijing Tiantan Hospital
    Jun 8, 2022

    Multiple Sclerosis Trial in Philadelphia (N-acetyl Cysteine)

    Enrolling by invitation
    • Multiple Sclerosis
    • N-acetyl Cysteine
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Aug 26, 2022

    Biomarker for Metachromatic Leukodystrophy (BioMeta) Disease

    Active, not recruiting
    • Peripheral Neuropathy
    • Muscle Weakness
      • Cairo, Egypt
      • +4 more
      May 12, 2021

      Genetics of Pediatric-Onset Motor Neuron and Neuromuscular

      Recruiting
      • Spinal Muscular Atrophy
      • +7 more
      • sample collection
      • Wilmington, Delaware
      • +2 more
      Mar 10, 2021

      Extracorporeal Shock Wave Therapy, Kinaesthesia, Sensory Disorders Trial in Elazig (ESWT)

      Completed
      • Extracorporeal Shock Wave Therapy
      • +2 more
      • ESWT
      • Elazığ, Turkey
        Furkan Bilek
      Apr 28, 2022

      Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy

      Not yet recruiting
      • X-linked Adrenoleukodystrophy
      • brainQuant module of brainTale-care platform
      • (no location specified)
      Jun 12, 2023

      Myeloarchitectonics Across Adulthood in Autism Spectrum Disorder

      Completed
      • Autism Spectrum Disorder
      • Anatomical MRI Scan
      • San Diego, California
        San Diego State University
      May 18, 2022

      LeukoSEQ: Whole Genome Sequencing asFirst-Line Diagnostic Tool

      Recruiting
      • Leukodystrophy
      • White Matter Disease
        • Philadelphia, Pennsylvania
          The Children's Hospital of Philadelphia
        Sep 13, 2022

        Scan-rescan Reproducibility of Myelin Sensitive MRI Techniques

        Completed
        • Myelin Integrity
        • myelin sensitive MRI scan
        • Basel, Switzerland
          Neurologische Klinik und Poliklinik, University Hospital Basel
        Dec 14, 2021

        Leber Congenital Amaurosis Trial in Shanghai (HG004)

        Recruiting
        • Leber Congenital Amaurosis
        • HG004
        • Shanghai, Shanghai, China
          Xinhua Hospital affiliated with Shanghai Jiao Tong UniversitySch
        Oct 12, 2023

        Liver Biopsy Following Gene Therapy For Hemophilia

        Not yet recruiting
        • Hemophilia A
        • Hemophilia B
        • Liver Biopsy
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Jun 27, 2023

        Exercise on Contactin-1 and Contactin-2 Level in Persons With

        Completed
        • Relapsing Remitting Multiple Sclerosis
          • Elazığ, Turkey
            Fırat university
          Apr 22, 2022

          Leber Congenital Amaurosis Trial in Shanghai (HG004)

          Recruiting
          • Leber Congenital Amaurosis
          • HG004
          • Shanghai, Shanghai, China
            Xinhua Hospital affiliated with Shanghai Jiao Tong University Sc
          Sep 26, 2023

          Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction Trial in Durham, Dallas (AAV1/SERCA2a)

          Recruiting
          • Heart Failure, Diastolic
          • Heart Failure With Preserved Ejection Fraction
          • AAV1/SERCA2a
          • Durham, North Carolina
          • +1 more
          Sep 23, 2023

          Study of Retinal Dystrophies Associated With Rare

          Active, not recruiting
          • Inherited Retinal Degeneration
          • Retinitis Pigmentosa
            • Phoenix, Arizona
            • +23 more
            Jan 24, 2023

            Schizophrenia Trial in Milan (Lurasidone)

            Recruiting
            • Schizophrenia
            • Milan, Lombardy, Italy
              U.O.C. Psichiatria - Fondazione IRCCS Ca' Granda Ospedale Maggio
            Apr 22, 2022

            Leber Congenital Amaurosis Trial (HG004)

            Not yet recruiting
            • Leber Congenital Amaurosis
            • (no location specified)
            Jun 13, 2023

            Solid Tumors Trial (afatinib)

            No longer available
            • Solid Tumors
            • (no location specified)
            Nov 7, 2022